Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay

F François-Clément Bidard (Institut Curie, Paris and Saint-Cloud; INSERM Centre d’Investigation Clinique 1428, Paris; Versailles–Saint-Quentin University, Paris–Saclay University, Saint Cloud, France) G Grégoire Gessain T Thomas Bachelot L Lucie Frechin A Anne Vincent-Salomon D Damien Drubay J Jerome Lemonnier (R&D Unicancer, Paris, France) T Thomas Walter F Frédérique Penault-Llorca A Anne-Laure Martin C Catherine Gaudin (Unicancer, Paris, France) A Antoine Bichat F Farah Sassi S Sylvain Berlemont M Mariana Chavez-MacGregor H Hope S. Rugo (City of Hope Comprehensive Cancer Center, Duarte, CA) C Cécile Badoual B Barbara Pistilli (Department of Cancer Medicine, Gustave Roussy, Villejuif, France) J Joana Ribeiro A Antonio Di Meglio M Magali Lacroix-Triki I Ines Vaz Luis M Marvin Lerousseau F Fabrice André